to Evaluate the Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Aug 2019
Price : $35 *
At a glance
- Drugs SPH 3127 (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Shanghai Pharmaceuticals Holding
- 27 Oct 2017 Status changed from not yet recruiting to recruiting.
- 17 Aug 2017 Planned End Date changed from 30 Aug 2018 to 30 Sep 2018.
- 17 Aug 2017 Planned primary completion date changed from 30 Aug 2018 to 30 Sep 2018.